Thirty-seven loss-of-function variants (30 distinct variants) were found in 36 breast cancer patients, one of whom carried both BARD1:c.1921C>T and BRCA2:c.3860delA (Fig. 1, Table 2 and Supplementary Table 1). Here, BRCA2 is linked to breast carcinoma.